Top

Published in:

Open Access 01-12-2021 | Breast Cancer | Study protocol

Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocol

Authors: M. Chartogne, A. Leclercq, B. Beaune, S. Boyas, C. Forestier, T. Martin, V. Thomas-Ollivier, S. Landry, H. Bourgeois, O. Cojocarasu, V. Pialoux, O. Zanna, L. A. Messonnier, A. Rahmani, B. Morel

Published in: BMC Cancer | Issue 1/2021

Abstract

Background

Cancer-related fatigue (CRF) is the most common side effect of cancer and cancer treatment. CRF prevalence is up to 50% in breast cancer patients and can continue several years after cancer remission. This persistent subjective sense of exhaustion is multifactorial. Numerous parameters have been evidenced to be related to CRF across biological, physical, psychological, social and/or behavioral dimensions. Although CRF has been studied for many years, the majority of previous studies focused on only one dimension, i.e., physical function. Moreover, few studies investigated CRF longitudinally with repeated measures. These are the two main obstacles that limit the understanding of CRF mechanisms. The purpose of this study is to create a biopsychosocial model of CRF with simultaneous and longitudinal anthropometric, clinical, biological, physical, psychological and sociological parameters.

Methods

BIOCARE FActory is a multicentric prospective study that will consist of an 18-month follow-up of 200 women diagnosed with breast cancer. Four visits will be scheduled at diagnosis, after treatments, and 12 and 18 months after diagnosis. The same procedure will be followed for each visit. Each session will be composed of anthropometric data collection, a semi-structured interview, cognitive tests, postural control tests, neuromuscular fatigability tests and a cardiorespiratory fitness test. Clinical and biological data will be collected during medical follow-ups. Participants will also complete questionnaires to assess psychological aspects and quality of life and wear an actigraphy device. Using a structural equation modeling analysis (SEM), collected data will build a biopsychosocial model of CRF, including the physiological, biological, psychological, behavioral and social dimensions of CRF.

Discussion

This study aims to highlight the dynamics of CRF and its correlates from diagnosis to post treatment. SEM analysis could examine some relations between potential mechanisms and CRF. Thus, the biopsychosocial model will contribute to a better understanding of CRF and its underlying mechanisms from diagnosis to the aftermaths of cancer and its treatments.

Trial registration

This study is registered at ClinicalTrials.gov (NCT04391543), May 2020.

Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, et al. Cancer-related fatigue, version 2.2015. J Natl Compr Cancer Netw. 2015 Aug;13(8):1012–39. https://doi.org/10.6004/jnccn.2015.0122.CrossRef

Minton O, Stone P. How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature. Breast Cancer Res Treat. 2008 Nov;112(1):5–13. https://doi.org/10.1007/s10549-007-9831-1.CrossRefPubMed

Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat. 2007 Oct;105(2):209–19. https://doi.org/10.1007/s10549-006-9447-x.CrossRefPubMed

McNeely ML, Courneya KS. Exercise programs for cancer-related fatigue: evidence and clinical guidelines. J Natl Compr Cancer Netw. 2010 Aug;8(8):945–53. https://doi.org/10.6004/jnccn.2010.0069.CrossRef

Bower JE, Asher A, Garet D, Petersen L, Ganz PA, Irwin MR, et al. Testing a biobehavioral model of fatigue before adjuvant therapy in women with breast cancer. Cancer. 2019 Feb 15;125(4):633–41. https://doi.org/10.1002/cncr.31827.CrossRefPubMed

Weis J. Cancer-related fatigue: prevalence, assessment and treatment strategies. Expert Rev Pharmacoecon Outcomes Res. 2011;11(4):441–6. https://doi.org/10.1586/erp.11.44.

Twomey R, Martin T, Temesi J, Culos-Reed SN, Millet GY. Tailored exercise interventions to reduce fatigue in cancer survivors: study protocol of a randomized controlled trial. BMC Cancer. 2018 Jul 24;18(1):757. https://doi.org/10.1186/s12885-018-4668-z.CrossRefPubMedPubMedCentral

Bower JE. Cancer-related fatigue--mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014 Oct;11(10):597–609. https://doi.org/10.1038/nrclinonc.2014.127.CrossRefPubMedPubMedCentral

Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol. 2005 Sep 20;23(27):6613–22. https://doi.org/10.1200/JCO.2005.07.024.CrossRefPubMed

10.

Van Esch L, Roukema JA, Ernst MF, Nieuwenhuijzen GAP, De Vries J. Combined anxiety and depressive symptoms before diagnosis of breast cancer. J Affect Disord. 2012 Feb;136(3):895–901. https://doi.org/10.1016/j.jad.2011.09.012.CrossRefPubMed

11.

Abrahams HJG, Gielissen MFM, Schmits IC, Verhagen CAHHVM, Rovers MM, Knoop H. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol. 2016 Mar 2;27(6):965–74. https://doi.org/10.1093/annonc/mdw099.CrossRefPubMed

12.

Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000 Feb;18(4):743–53. https://doi.org/10.1200/JCO.2000.18.4.743.CrossRefPubMed

13.

Cella D, Kallich J, McDermott A, Xu X. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol. 2004 Jun;15(6):979–86. https://doi.org/10.1093/annonc/mdh235.CrossRefPubMed

14.

Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res. 2006 May 1;12(9):2759–66. https://doi.org/10.1158/1078-0432.CCR-05-2398.CrossRefPubMed

15.

Kilgour RD, Vigano A, Trutschnigg B, Hornby L, Lucar E, Bacon SL, et al. Cancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer. J Cachexia Sarcopenia Muscle. 2010 Dec 17;1(2):177–85. https://doi.org/10.1007/s13539-010-0016-0.CrossRefPubMedPubMedCentral

16.

Yavuzsen T, Davis MP, Ranganathan VK, Walsh D, Siemionow V, Kirkova J, et al. Cancer-related fatigue: central or peripheral? J Pain Symptom Manag. 2009 Oct;38(4):587–96. https://doi.org/10.1016/j.jpainsymman.2008.12.003.CrossRef

17.

Kisiel-Sajewicz K, Davis MP, Siemionow V, Seyidova-Khoshknabi D, Wyant A, Walsh D, et al. Lack of muscle contractile property changes at the time of perceived physical exhaustion suggests central mechanisms contributing to early motor task failure in patients with cancer-related fatigue. J Pain Symptom Manag. 2012 Sep;44(3):351–61. https://doi.org/10.1016/j.jpainsymman.2011.08.007.CrossRef

18.

Kisiel-Sajewicz K, Siemionow V, Seyidova-Khoshknabi D, Davis MP, Wyant A, Ranganathan VK, et al. Myoelectrical manifestation of fatigue less prominent in patients with cancer related fatigue. PLoS One. 2013 Dec 31;8(12):e83636. https://doi.org/10.1371/journal.pone.0083636.CrossRefPubMedPubMedCentral

19.

Grisold W, Grisold A, Löscher WN. Neuromuscular complications in cancer. J Neurol Sci. 2016 Aug 15;367:184–202. https://doi.org/10.1016/j.jns.2016.06.002.CrossRefPubMed

20.

Chartogne M, Rahmani A, Landry S, Bourgeois H, Peyrot N. Neuromuscular, Psychological, and Sleep Predictors of Cancer-Related Fatigue in Cancer Patients. In: Morel B. Psychological, and Sleep Predictors of Cancer-Related Fatigue in Cancer Patients. Clin Breast Cancer: Neuromuscular; 2020 Dec 9.

21.

Neil SE, Klika RJ, Garland SJ, McKenzie DC, Campbell KL. Cardiorespiratory and neuromuscular deconditioning in fatigued and non-fatigued breast cancer survivors. Support Care Cancer. 2013 Mar;21(3):873–81. https://doi.org/10.1007/s00520-012-1600-y.CrossRefPubMed

22.

Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007 Oct 9;50(15):1435–41. https://doi.org/10.1016/j.jacc.2007.06.037.CrossRefPubMed

23.

Medysky ME, Temesi J, Culos-Reed SN, Millet GY. Exercise, sleep and cancer-related fatigue: are they related? Neurophysiol Clin. 2017 Apr 5;47(2):111–22. https://doi.org/10.1016/j.neucli.2017.03.001.CrossRefPubMed

24.

Martin T, Twomey R, Medysky ME, Temesi J, Culos-Reed SN, Millet GY. The Relationship between Fatigue and Actigraphy-Derived Sleep and Rest-Activity Patterns in Cancer Survivors. 2019 Sep 6;

25.

Veni T, Boyas S, Beaune B, Bourgeois H, Rahmani A, Landry S, et al. Handgrip fatiguing exercise can provide objective assessment of cancer-related fatigue: a pilot study. Support Care Cancer. 2019 Jan;27(1):229–38. https://doi.org/10.1007/s00520-018-4320-0.CrossRefPubMed

26.

Lockefeer JPM, De Vries J. What is the relationship between trait anxiety and depressive symptoms, fatigue, and low sleep quality following breast cancer surgery? Psychooncology. 2013 May;22(5):1127–33. https://doi.org/10.1002/pon.3115.CrossRefPubMed

27.

Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998 May;16(5):1689–96. https://doi.org/10.1200/JCO.1998.16.5.1689.CrossRefPubMed

28.

Spencer KW. Significance of the breast to the individual and society. Plast Surg Nurs. 1996;16(3):131–2. https://doi.org/10.1097/00006527-199623000-00003.CrossRefPubMed

29.

Landry S, Chasles G, Pointreau Y, Bourgeois H, Boyas S. Influence of an adapted physical activity program on self-esteem and quality of life of breast Cancer patients after mastectomy. Oncology. 2018 May 30;95(3):188–91. https://doi.org/10.1159/000489265.CrossRefPubMed

30.

Jenkins V, Thwaites R, Cercignani M, Sacre S, Harrison N, Whiteley-Jones H, et al. A feasibility study exploring the role of pre-operative assessment when examining the mechanism of “chemo-brain” in breast cancer patients. Springerplus. 2016 Mar 31;5(1):390. https://doi.org/10.1186/s40064-016-2030-y.CrossRefPubMedPubMedCentral

31.

O’Farrell E, MacKenzie J, Collins B. Clearing the air: a review of our current understanding of “chemo fog”. Curr Oncol Rep. 2013 Jun;15(3):260–9. https://doi.org/10.1007/s11912-013-0307-7.CrossRefPubMed

32.

Prins JB, Bos E, Huibers MJH, Servaes P, van der Werf SP, van der Meer JWM, et al. Social support and the persistence of complaints in chronic fatigue syndrome. Psychother Psychosom. 2004 Jun;73(3):174–82. https://doi.org/10.1159/000076455.CrossRefPubMed

33.

Fagundes CP, Lindgren ME, Shapiro CL, Kiecolt-Glaser JK. Child maltreatment and breast cancer survivors: social support makes a difference for quality of life, fatigue and cancer stress. Eur J Cancer. 2012 Mar;48(5):728–36. https://doi.org/10.1016/j.ejca.2011.06.022.CrossRefPubMedPubMedCentral

34.

Stone P, Richards M, A’Hern R, Hardy J. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol. 2000 May;11(5):561–7. https://doi.org/10.1023/A:1008331230608.CrossRefPubMed

35.

Humpel N, Iverson DC. Sleep quality, fatigue and physical activity following a cancer diagnosis. Eur J Cancer Care (Engl). 2010 Nov;19(6):761–8. https://doi.org/10.1111/j.1365-2354.2009.01126.x.CrossRef

36.

De Vries J, Van der Steeg AF, Roukema JA. Trait anxiety determines depressive symptoms and fatigue in women with an abnormality in the breast. Br J Health Psychol. 2009 Feb;14(Pt 1):143–57. https://doi.org/10.1348/135910708X310200.CrossRefPubMed

37.

Courtier N, Gambling T, Enright S, Barrett-Lee P, Abraham J, Mason MD. Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer. Support Care Cancer. 2013 Jan;21(1):173–81. https://doi.org/10.1007/s00520-012-1508-6.CrossRefPubMed

38.

Brownstein CG, Twomey R, Temesi J, Wrightson JG, Martin T, Medysky ME, et al. Physiological and psychosocial correlates of cancer related fatigue. medRxiv. 2020 Oct 16.

39.

Jones PR, Pearson J. Anthropometric determination of leg fat and muscle plus bone volumes in young male and female adults. J Physiol Lond. 1969 Oct;204(2):63P–6P.PubMed

40.

Rolland Y, Lauwers-Cances V, Cournot M, Nourhashémi F, Reynish W, Rivière D, et al. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc. 2003 Aug;51(8):1120–4. https://doi.org/10.1046/j.1532-5415.2003.51362.x.CrossRefPubMed

41.

Arcuri GG, Palladini L, Dumas G, Lemoignan J, Gagnon B. Exploring the measurement properties of the Montreal cognitive assessment in a population of people with cancer. Support Care Cancer. 2015 Sep;23(9):2779–87. https://doi.org/10.1007/s00520-015-2643-7.CrossRefPubMed

42.

Poppelreuter M, Weis J, Külz AK, Tucha O, Lange KW, Bartsch HH. Cognitive dysfunction and subjective complaints of cancer patients. A cross-sectional study in a cancer rehabilitation Centre. Eur J Cancer. 2004 Jan;40(1):43–9. https://doi.org/10.1016/j.ejca.2003.08.001.CrossRefPubMed

43.

Campbell KL, Kam JWY, Neil-Sztramko SE, Liu Ambrose T, Handy TC, Lim HJ, et al. Effect of aerobic exercise on cancer-associated cognitive impairment: a proof-of-concept RCT. Psychooncology. 2018;27(1):53–60. https://doi.org/10.1002/pon.4370.CrossRefPubMed

44.

Deschamps T, Sauvaget A, Pichot A, Valrivière P, Maroulidès M, Bois A, et al. Posture-cognitive dual-tasking: a relevant marker of depression-related psychomotor retardation. An illustration of the positive impact of repetitive transcranial magnetic stimulation in patients with major depressive disorder. J Psychiatr Res. 2016 Aug 20;83:86–93. https://doi.org/10.1016/j.jpsychires.2016.08.013.CrossRefPubMed

45.

Tucker R. The anticipatory regulation of performance: the physiological basis for pacing strategies and the development of a perception-based model for exercise performance. Br J Sports Med. 2009 Jun;43(6):392–400. https://doi.org/10.1136/bjsm.2008.050799.CrossRefPubMed

46.

Burnley M. Estimation of critical torque using intermittent isometric maximal voluntary contractions of the quadriceps in humans. J Appl Physiol. 2009 Mar;106(3):975–83. https://doi.org/10.1152/japplphysiol.91474.2008.CrossRefPubMed

47.

Poole DC, Burnley M, Vanhatalo A, Rossiter HB, Jones AM. Critical power: an important fatigue threshold in exercise physiology. Med Sci Sports Exerc. 2016;48(11):2320–34. https://doi.org/10.1249/MSS.0000000000000939.CrossRefPubMedPubMedCentral

48.

Merton PA. Voluntary strength and fatigue. J Physiol Lond. 1954 Mar 29;123(3):553–64. https://doi.org/10.1113/jphysiol.1954.sp005070.CrossRefPubMedPubMedCentral

49.

Prado CMM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008 Jul;9(7):629–35. https://doi.org/10.1016/S1470-2045(08)70153-0.CrossRefPubMed

50.

Giesinger JM, Kuijpers W, Young T, Tomaszewski KA, Friend E, Zabernigg A, et al. Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain. Health Qual Life Outcomes. 2016 Jun 7;14(1):87. https://doi.org/10.1186/s12955-016-0489-4.CrossRefPubMedPubMedCentral

51.

Kecke S, Ernst J, Einenkel J, Singer S, Hinz A. Psychometric properties of the fatigue questionnaire EORTC QLQ-FA12 in a sample of female Cancer patients. J Pain Symptom Manag. 2017 Aug 12;54(6):922–8. https://doi.org/10.1016/j.jpainsymman.2017.08.007.CrossRef

52.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–70. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x.CrossRefPubMed

53.

Lakens D. Sample Size Justification. 2021 Jan:4.

54.

Kline RB. Software review: software programs for structural equation modeling: Amos, EQS, and LISREL. J Psychoeduc Assess. 1998 Dec;16(4):343–64. https://doi.org/10.1177/073428299801600407.CrossRef

55.

Grimm LG, Yarnold PR. Reading and understanding MORE multivariate statistics; 2000.

56.

Francis DJ. An introduction to structural equation models. J Clin Exp Neuropsychol. 1988 Oct;10(5):623–39. https://doi.org/10.1080/01688638808402800.CrossRefPubMed

57.

Rosseel Y. Lavaan: An R package for structural equation modeling and more. Version 0.5–12 (BETA). J Stat Softw. 2012;

58.

Byrne BM. A primer of LISREL: basic applications and programming for confirmatory factor analytic models; 2012.

59.

Arbuckle JL, Wothke W. Amos 4.0 user’s guide. 1999;

60.

Schumacker RE, Lomax RG. A beginner’s guide to structural equation modeling. 3rd ed. New York: Routledge; 2010.

61.

Tabachnick BG, Fidell LS, Ullman JB. Using multivariate statistics; 2007.

62.

Byrne BM. Structural equation modeling with EQS and EQS/windows: basic concepts, applications, and programming; 1994.

63.

Steiger JH. Structural model evaluation and modification: an interval estimation approach. Multivariate Behav Res. 1990 Apr 1;25(2):173–80. https://doi.org/10.1207/s15327906mbr2502_4.CrossRefPubMed

64.

MacCallum R. Specification searches in covariance structure modeling. Psychol Bull. 1986;100(1):107–20. https://doi.org/10.1037/0033-2909.100.1.107.CrossRef

65.

Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014 Jun 10;32(17):1840–50. https://doi.org/10.1200/JCO.2013.53.4495.CrossRefPubMedPubMedCentral

66.

Pearson EJM, Morris ME, McKinstry CE. Cancer-related fatigue: appraising evidence-based guidelines for screening, assessment and management. Support Care Cancer. 2016 Apr 26;24(9):3935–42. https://doi.org/10.1007/s00520-016-3228-9.CrossRefPubMed

67.

Fabi A, Bhargava R, Fatigoni S, Guglielmo M, Horneber M, Roila F, et al. Cancer-related fatigue: ESMO clinical practice guidelines for diagnosis and treatment. Ann Oncol. 2020 Mar 12;31(6):713–23. https://doi.org/10.1016/j.annonc.2020.02.016.CrossRefPubMed

68.

Seyidova-Khoshknabi D, Davis MP, Walsh D. Review article: a systematic review of cancer-related fatigue measurement questionnaires. Am J Hosp Palliat Care. 2011 Mar;28(2):119–29. https://doi.org/10.1177/1049909110381590.CrossRefPubMed

69.

O’Higgins CM, Brady B, O’Connor B, Walsh D, Reilly RB. The pathophysiology of cancer-related fatigue: current controversies. Support Care Cancer. 2018 Oct;26(10):3353–64. https://doi.org/10.1007/s00520-018-4318-7.CrossRefPubMed

70.

Norman K, Wirth R, Neubauer M, Eckardt R, Stobäus N. The bioimpedance phase angle predicts low muscle strength, impaired quality of life, and increased mortality in old patients with cancer. J Am Med Dir Assoc. 2015 Feb;16(2):173.e17–22.CrossRef

Title: Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocol
Authors: M. Chartogne
A. Leclercq
B. Beaune
S. Boyas
C. Forestier
T. Martin
V. Thomas-Ollivier
S. Landry
H. Bourgeois
O. Cojocarasu
V. Pialoux
O. Zanna
L. A. Messonnier
A. Rahmani
B. Morel
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Breast Cancer
Breast Cancer
Cancer Fatigue
Fatigue
Published in: BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-021-08831-3

2024 ASCO Annual Meeting Coverage

Highlights of the Day: Breast cancer – metastatic

Breast Cancer Video

In this session, Dr. Wolff provides his key takeaways from the data presented in the metastatic breast cancer oral abstract session at ASCO 2024.

Watch now

Highlights of the Day: Gynecologic cancer

Gynecologic Cancer Video

Highlights of the Day: Breast Cancer – local/regional/adjuvant

Breast Cancer Video

Neoadjuvant dual immunotherapy improves melanoma outcomes

04-06-2024 Melanoma News

» View more highlights on the ASCO 2024 congress hub page

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Image Credits

ASCO 2024 | Highlights of the Day: Breast cancer – metastatic/© 2024 American Society of Clinical Oncology, all rights reserved., ASCO 2024 | Highlights of the Day: Gynecologic Cancer/© 2024 American Society of Clinical Oncology, all rights reserved., ASCO 2024 | Highlights of the Day: Breast Cancer – local/regional/adjuvant/© 2024 American Society of Clinical Oncology, all rights reserved., Melanoma/© selvanegra / Getty Images / iStock, Antibody drug conjugated with cytotoxic payload/© Love Employee / Getty images / iStock

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Methods

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2021

Delayed or failure to follow-up abnormal breast cancer screening mammograms in primary care: a systematic review

FAM83H-AS1/miR-485-5p/MEF2D axis facilitates proliferation, migration and invasion of hepatocellular carcinoma cells

Relationship between chronic exposure to ambient air pollution and mental health in Korean adult cancer survivors and the general population

The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma

Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial

Effectiveness of self-help workbook intervention on quality of life in cancer patients receiving chemotherapy: results of a randomized controlled trial